Form 4: BIODESIX Director Hany Massarany Converts Restricted Stock Units into Common Shares

BIODESIX Director Hany Massarany reported the conversion of 26,368 restricted stock units into common stock, increasing his direct beneficial ownership to 310,135 shares.

Summary

• Hany Massarany, a Director of BIODESIX INC (BDSX), reported changes in his beneficial ownership of company securities.
• On July 1, 2025, 26,368 Restricted Stock Units (RSUs) held by Mr. Massarany fully vested and settled.
• These RSUs converted into 26,368 shares of the Issuer's Common Stock.
• Following this transaction, Mr. Massarany directly beneficially owns 310,135 shares of Common Stock.
• An additional 53,364 shares of Common Stock are indirectly beneficially owned by Mr. Massarany through the Massarany Family Trust dated November 15, 2012.
• The total beneficial ownership reported by Mr. Massarany is 363,499 shares (310,135 direct + 53,364 indirect).

Sentiment

Score: 7

Explanation: The conversion of restricted stock units into common shares by a director is generally a positive sign, indicating vesting and continued alignment of interests with shareholders. It's a routine insider transaction, not indicative of major positive or negative news, hence a neutral-to-positive score.

Positives

• The conversion of Restricted Stock Units into common shares indicates vesting and a continued long-term commitment by a director.
• Increased direct beneficial ownership by a director aligns management interests with those of shareholders.

Future Outlook

This Form 4 reports a completed transaction where Restricted Stock Units vested and settled on July 1, 2025, converting into common stock. No forward-looking statements or guidance are provided beyond this transaction.

Industry Context

This filing is a routine insider transaction report and does not provide specific industry context or trends.

Related Party Transactions

• Indirect beneficial ownership of 53,364 shares of Common Stock through the Massarany Family Trust dated November 15, 2012, where Mr. Massarany is a trustee.

Stakeholder Impact

• Shareholders: Increased direct ownership by a director may be viewed positively as it aligns management interests with shareholder value.

Key Dates

Keywords

BIODESIX INC, BDSX, Hany Massarany, Form 4, SEC filing, insider transaction, beneficial ownership, restricted stock units, RSU conversion, common stock, director ownership